CLASP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.739980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.243200E-01
Normal-vs-Stage2
3.790400E-02
Normal-vs-Stage3
1.032350E-01
Normal-vs-Stage4
4.170600E-01
Stage1-vs-Stage2
1.581420E-01
Stage1-vs-Stage3
5.638400E-02
Stage1-vs-Stage4
9.857000E-01
Stage2-vs-Stage3
2.786500E-04
Stage2-vs-Stage4
2.255800E-01
Stage3-vs-Stage4
5.161700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.999970E-01
Normal-vs-AfricanAmerican
1.736400E-01
Normal-vs-Asian
5.491900E-02
Caucasian-vs-AfricanAmerican
8.548800E-01
Caucasian-vs-Asian
2.846200E-01
AfricanAmerican-vs-Asian
5.137800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.061990E-01
Normal-vs-Female
2.821600E-01
Male-vs-Female
3.149800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.448600E-01
Normal-vs-Age(41-60Yrs)
1.209570E-01
Normal-vs-Age(61-80Yrs)
2.369200E-01
Normal-vs-Age(81-100Yrs)
1.300390E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.302400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.241800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.105600E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.835200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.808500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.529800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.409700E-02
Normal-vs-Daily Drinker
1.797800E-02
Normal-vs-Weekly Drinker
5.230300E-02
Normal-vs-Occasional Drinker
5.997800E-01
Normal-vs-Social Drinker
4.674800E-01
Non Drinker-vs-Daily Drinker
8.214000E-01
Non Drinker-vs-Weekly Drinker
6.600800E-01
Non Drinker-vs-Occasional Drinker
3.288200E-01
Non Drinker-vs-Social Drinker
1.998400E-01
Daily Drinker-vs-Weekly Drinker
5.580400E-01
Daily Drinker-vs-Occasional Drinker
2.936600E-01
Daily Drinker-vs-Social Drinker
1.723820E-01
Weekly Drinker-vs-Occasional Drinker
4.543600E-01
Weekly Drinker-vs-Social Drinker
3.320400E-01
Occasional Drinker-vs-Social Drinker
9.834200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.822400E-01
Normal-vs-Grade 2
8.252500E-02
Normal-vs-Grade 3
1.040240E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.458150E-01
Grade 1-vs-Grade 3
1.236360E-01
Grade 1-vs-Grade 4
2.822400E-01
Grade 2-vs-Grade 3
7.495800E-01
Grade 2-vs-Grade 4
8.252500E-02
Grade 3-vs-Grade 4
1.040240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.000000E-02
Normal-vs-NonDiabetic
2.155800E-01
Diabetic-vs-NonDiabetic
4.417800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.842400E-02
Normal-vs-NoPancreatitis
1.928820E-01
Pancreatitis-vs-NoPancreatitis
3.734800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.275600E-01
Normal-vs-N1
3.645500E-02
N0-vs-N1
1.469400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.601700E-03
Normal-vs-TP53-NonMutant
5.519800E-01
TP53-Mutant-vs-TP53-NonMutant
1.843690E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
